SEMA3F inhibitors are chemicals that specifically interact with and impede the function of semaphorin 3F (SEMA3F), a member of the semaphorin family. Semaphorins are a large family of proteins that were originally identified as axon guidance cues during neural development. SEMA3F, in particular, is known for its role in the regulation of cellular processes including cell migration, proliferation, and cytoskeletal organization. This is achieved through SEMA3F's interaction with its neuropilin and plexin receptors, which transduce extracellular signals into intracellular responses that affect the cytoskeleton and cellular dynamics. Inhibitors of SEMA3F, therefore, are molecules that bind to SEMA3F or its receptors, blocking SEMA3F's ability to engage and activate its signaling cascade, thus modulating the downstream processes influenced by this pathway.
The chemical class of SEMA3F inhibitors is diverse, encompassing a range of molecules that can obstruct the SEMA3F signaling pathway through various mechanisms. Some inhibitors may achieve this by directly binding to the SEMA3F protein, altering its conformation and preventing its interaction with its receptors. Others may bind to the neuropilin or plexin receptors, either preventing SEMA3F from binding or inhibiting the receptor's ability to propagate the signal even after SEMA3F binding. The precise structure and mode of action of these inhibitors can vary greatly, from small molecules to larger biologics, each with its unique interaction with the SEMA3F pathway. By influencing the SEMA3F signaling pathway, these inhibitors can modulate the behavior of cells in response to SEMA3F, affecting how they move, grow, and organize, which are fundamental aspects of cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, potentially affecting SEMA3F signaling through the PI3K/Akt pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, which can affect SEMA3F-related signaling cascades. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Also an MEK inhibitor, which can impact MAPK/ERK signaling related to SEMA3F. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, affecting RhoA/ROCK signaling pathways, potentially influencing SEMA3F signaling cascades. | ||||||
XL413 | 1169562-71-3 | sc-474909 | 5 mg | $275.00 | ||
A Cdc42 inhibitor, potentially affecting pathways influenced by SEMA3F. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, potentially affecting downstream signaling of SEMA3F. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially impacting pathways related to SEMA3F signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which can influence various signaling pathways including those possibly related to SEMA3F. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR inhibitor, which might indirectly influence SEMA3F signaling pathways as EGFR pathways can intersect with SEMA3F routes. | ||||||